Cytokinetics, Incorporated (NASDAQ:CYTK) Q2 2023 Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ:CYTK) Q2 2023 Earnings Call Transcript August 3, 2023

Cytokinetics, Incorporated misses on earnings expectations. Reported EPS is $-1.34 EPS, expectations were $1.23.

Operator: Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Second Quarter 2020 Conference Call. [Operator Instructions] I’ll now turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.

Diane...